Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

BACKGROUND: For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined real-world population-based comparative effectiveness of second-line ipilimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wei Fang, Beca, Jaclyn M., Croxford, Ruth, Isaranawatchai, Wanrudee, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Hanna, Timothy P., Chan, Kelvin K.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158109/
https://www.ncbi.nlm.nih.gov/pubmed/32293341
http://dx.doi.org/10.1186/s12885-020-06798-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158109/
https://www.ncbi.nlm.nih.gov/pubmed/32293341
http://dx.doi.org/10.1186/s12885-020-06798-1

Ejemplares similares